BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 31878135)

  • 21. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
    Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
    Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel diaziridinylquinone-acridine conjugates.
    Di Francesco AM; Mayalarp SP; Kim S; Butler J; Lee M
    Anticancer Drugs; 2003 Sep; 14(8):601-15. PubMed ID: 14501382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel piperine analogue exerts in vivo antitumor effect by inducing oxidative, antiangiogenic and immunomodulatory actions.
    Ferreira RC; Batista TM; Duarte SS; Silva DKF; Lisboa TMH; Cavalcanti RFP; Leite FC; Mangueira VM; Sousa TKG; Abrantes RA; Trindade EOD; Athayde-Filho PF; Brandão MCR; Medeiros KCP; Farias DF; Sobral MV
    Biomed Pharmacother; 2020 Aug; 128():110247. PubMed ID: 32450524
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
    Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
    J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic activity of acridin-3,6-diyl dithiourea hydrochlorides in human leukemia line HL-60 and resistant subline HL-60/ADR.
    Vantová Z; Paulíková H; Sabolová D; Kozurková M; Suchánová M; Janovec L; Kristian P; Imrich J
    Int J Biol Macromol; 2009 Aug; 45(2):174-80. PubMed ID: 19414028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 2-Thienyl- and 2-Benzothienyl-Substituted 6-(2-Imidazolinyl)Benzothiazoles: Synthesis; in vitro Evaluation of Antitumor Effects and Assessment of Mitochondrial Toxicity.
    Racané L; Sedić M; Ilić N; Aleksić M; Pavelić SK; Karminski-Zamola G
    Anticancer Agents Med Chem; 2017; 17(1):57-66. PubMed ID: 27141878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
    Holm B; Jensen PB; Sehested M
    Cancer Chemother Pharmacol; 1996; 38(3):203-9. PubMed ID: 8646793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 9-substituted acridine derivatives with long half-life and potent antitumor activity: synthesis and structure-activity relationships.
    Su TL; Chou TC; Kim JY; Huang JT; Ciszewska G; Ren WY; Otter GM; Sirotnak FM; Watanabe KA
    J Med Chem; 1995 Aug; 38(17):3226-35. PubMed ID: 7650675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A G-quadruplex-interactive potent small-molecule inhibitor of telomerase exhibiting in vitro and in vivo antitumor activity.
    Gowan SM; Harrison JR; Patterson L; Valenti M; Read MA; Neidle S; Kelland LR
    Mol Pharmacol; 2002 May; 61(5):1154-62. PubMed ID: 11961134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in vitro antitumor evaluation of some new thiophenes and thieno[2,3-d]pyrimidine derivatives.
    Fouad MM; El-Bendary ER; Suddek GM; Shehata IA; El-Kerdawy MM
    Bioorg Chem; 2018 Dec; 81():587-598. PubMed ID: 30248510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The influence of three newly synthesized pyrimidine-containing compounds on micronucleus induction and tumor growth.
    Nersesyan A; Muradyan R; Arsenyan F
    J BUON; 2007; 12(4):521-7. PubMed ID: 18067211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potent inhibition of scrapie prion replication in cultured cells by bis-acridines.
    May BC; Fafarman AT; Hong SB; Rogers M; Deady LW; Prusiner SB; Cohen FE
    Proc Natl Acad Sci U S A; 2003 Mar; 100(6):3416-21. PubMed ID: 12626750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dinuclear Ru
    Lenis-Rojas OA; Roma-Rodrigues C; Fernandes AR; Marques F; Pérez-Fernández D; Guerra-Varela J; Sánchez L; Vázquez-García D; López-Torres M; Fernández A; Fernández JJ
    Inorg Chem; 2017 Jun; 56(12):7127-7144. PubMed ID: 28585811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, antitumor screening and cell cycle analysis of novel benzothieno[3,2-b]pyran derivatives.
    Zaher AF; Abuel-Maaty SM; El-Nassan HB; Amer SA; Abdelghany TM
    J Enzyme Inhib Med Chem; 2016; 31(sup4):145-153. PubMed ID: 27590401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant and anticancer activity of synthesized 4-amino-5-((aryl substituted)-4H-1,2,4-triazole-3-yl)thio-linked hydroxamic acid derivatives.
    Das M; Das B; Samanta A
    J Pharm Pharmacol; 2019 Sep; 71(9):1400-1411. PubMed ID: 31218685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, X-ray crystal structures, stabilities, and in vitro cytotoxic activities of new heteroarylacrylonitriles.
    Saczewski F; Reszka P; Gdaniec M; Grünert R; Bednarski PJ
    J Med Chem; 2004 Jun; 47(13):3438-49. PubMed ID: 15189040
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    Gutiérrez-Lovera C; Martínez-Val J; Cabezas-Sainz P; López R; Rubiolo JA; Sánchez L
    Toxicol Mech Methods; 2019 Sep; 29(7):478-487. PubMed ID: 31050327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative biodistribution and metabolism of carbon-11-labeled N-[2-(dimethylamino)ethyl]acridine-4-carboxamide and DNA-intercalating analogues.
    Osman S; Rowlinson-Busza G; Luthra SK; Aboagye EO; Brown GD; Brady F; Myers R; Gamage SA; Denny WA; Baguley BC; Price PM
    Cancer Res; 2001 Apr; 61(7):2935-44. PubMed ID: 11306471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-(Benzo[d][1,3]dioxol-5-ylamino)-N-(4-fluorophenyl)thiophene-2-carboxamide overcomes cancer chemoresistance via inhibition of angiogenesis and P-glycoprotein efflux pump activity.
    Mudududdla R; Guru SK; Wani A; Sharma S; Joshi P; Vishwakarma RA; Kumar A; Bhushan S; Bharate SB
    Org Biomol Chem; 2015 Apr; 13(14):4296-309. PubMed ID: 25758415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.